Literature DB >> 26719253

MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.

Silvana Opp1, Daniel A S A Vieira1, Bianca Schulte1, Sumit K Chanda2, Felipe Diaz-Griffero3.   

Abstract

UNLABELLED: MxB restricts HIV-1 infection by directly interacting with the HIV-1 core, which is made of viral capsid; however, the contribution of MxB to the HIV-1 restriction observed in alpha interferon (IFN-α)-treated human cells is unknown. To understand this contribution, we used HIV-1 bearing the G208R capsid mutant (HIV-1-G208R), which overcomes the restriction imposed by cells expressing MxB. Here we showed that the reason why MxB does not block HIV-1-G208R is that MxB does not interact with HIV-1 cores bearing the mutation G208R. To understand whether MxB contributes to the HIV-1 restriction imposed by IFN-α-treated human cells, we challenged IFN-α-treated cells with HIV-G208R and found that MxB does not contribute to the restriction imposed by IFN-α-treated cells. To more directly test the contribution of MxB, we challenged IFN-α-treated human cells that are knocked out for the expression of MxB with HIV-1. These experiments suggested that MxB does not contribute to the HIV-1 restriction observed in IFN-α-treated human cells. IMPORTANCE: MxB is a restriction factor that blocks HIV-1 infection in human cells. Although it has been postulated that MxB is the factor that blocks HIV-1 infection in IFN-α-treated cells, this is a hard concept to grasp due to the great number of genes that are induced by IFN-α in cells from the immune system. The work presented here elegantly demonstrates that MxB has minimal or no contribution to the ability of IFN-α-treated human cells to block HIV-1 infection. Furthermore, this work suggests the presence of novel restriction factors in IFN-α-treated human cells that block HIV-1 infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26719253      PMCID: PMC4810631          DOI: 10.1128/JVI.03146-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.

Authors:  Bianca Schulte; Cindy Buffone; Silvana Opp; Francesca Di Nunzio; Daniel Augusto De Souza Aranha Vieira; Alberto Brandariz-Nuñez; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

2.  Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.

Authors:  Georg Kochs; Christian Janzen; Heinz Hohenberg; Otto Haller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein.

Authors:  J Pavlovic; T Zürcher; O Haller; P Staeheli
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.

Authors:  Felipe Diaz-Griffero; Michel Perron; Kathleen McGee-Estrada; Robert Hanna; Pierre V Maillard; Didier Trono; Joseph Sodroski
Journal:  Virology       Date:  2008-06-30       Impact factor: 3.616

5.  Inhibition of a large double-stranded DNA virus by MxA protein.

Authors:  Christopher L Netherton; Jennifer Simpson; Otto Haller; Thomas E Wileman; Haru-Hisa Takamatsu; Paul Monaghan; Geraldine Taylor
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

6.  Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope.

Authors:  K Melén; P Keskinen; T Ronni; T Sareneva; K Lounatmaa; I Julkunen
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

7.  cDNA structures and regulation of two interferon-induced human Mx proteins.

Authors:  M Aebi; J Fäh; N Hurt; C E Samuel; D Thomis; L Bazzigher; J Pavlovic; O Haller; P Staeheli
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus.

Authors:  M Frese; G Kochs; U Meier-Dieter; J Siebler; O Haller
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Host and viral determinants for MxB restriction of HIV-1 infection.

Authors:  Kenneth A Matreyek; Weifeng Wang; Erik Serrao; Parmit Kumar Singh; Henry L Levin; Alan Engelman
Journal:  Retrovirology       Date:  2014-10-25       Impact factor: 4.602

Review 10.  Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation.

Authors:  Antonia A Dominguez; Wendell A Lim; Lei S Qi
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-16       Impact factor: 94.444

View more
  14 in total

1.  Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection.

Authors:  Bin Xu; Qinghua Pan; Chen Liang
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 2.  Capsid-Dependent Host Factors in HIV-1 Infection.

Authors:  Masahiro Yamashita; Alan N Engelman
Journal:  Trends Microbiol       Date:  2017-05-18       Impact factor: 17.079

3.  Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms.

Authors:  Brady J Summers; Katherine M Digianantonio; Sarah S Smaga; Pei-Tzu Huang; Kaifeng Zhou; Eva E Gerber; Wei Wang; Yong Xiong
Journal:  Cell Host Microbe       Date:  2019-08-14       Impact factor: 21.023

4.  A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.

Authors:  Molly OhAinle; Louisa Helms; Jolien Vermeire; Ferdinand Roesch; Daryl Humes; Ryan Basom; Jeffrey J Delrow; Julie Overbaugh; Michael Emerman
Journal:  Elife       Date:  2018-12-06       Impact factor: 8.140

5.  The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.

Authors:  Cindy Buffone; Juliane Kutzner; Silvana Opp; Alicia Martinez-Lopez; Anastasia Selyutina; Si Ana Coggings; Lydia R Studdard; Lingmei Ding; Baek Kim; Paul Spearman; Torsten Schaller; Felipe Diaz-Griffero
Journal:  Virology       Date:  2019-03-30       Impact factor: 3.616

6.  Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.

Authors:  Lorenzo Bulli; Luis Apolonia; Juliane Kutzner; Darja Pollpeter; Caroline Goujon; Nikolas Herold; Sarah-Marie Schwarz; Yannick Giernat; Oliver T Keppler; Michael H Malim; Torsten Schaller
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins.

Authors:  Dominik Hotter; Daniel Sauter; Frank Kirchhoff
Journal:  Small GTPases       Date:  2016-06-08

8.  The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.

Authors:  Suzannah J Rihn; Toshana L Foster; Idoia Busnadiego; Muhamad Afiq Aziz; Joseph Hughes; Stuart J D Neil; Sam J Wilson
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

9.  Naturally Occurring Mutations in HIV-1 CRF01_AE Capsid Affect Viral Sensitivity to Restriction Factors.

Authors:  Emi E Nakayama; Akatsuki Saito; Tahmina Sultana; Zhuan Jin; Kyotaro Nohata; Masato Shibata; Miho Hosoi; Kazushi Motomura; Tatsuo Shioda; Somchai Sangkitporn; Ruangchai Loket; Siriphan Saeng-Aroon
Journal:  AIDS Res Hum Retroviruses       Date:  2018-02-13       Impact factor: 2.205

Review 10.  Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?

Authors:  Rebecca P Sumner; Lucy G Thorne; Doug L Fink; Hataf Khan; Richard S Milne; Greg J Towers
Journal:  Front Immunol       Date:  2017-10-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.